<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">465794092</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180323112033.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170327e19900301xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/BF02482616</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/BF02482616</subfield>
  </datafield>
  <datafield tag="100" ind1="1" ind2=" ">
   <subfield code="a">Hindle</subfield>
   <subfield code="D">N.</subfield>
   <subfield code="u">Alberta Children's Hospital &amp; Foothills Hospital, Calgary, Canada</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="245" ind1="1" ind2="0">
   <subfield code="a">Critical mass retinopathy of prematurity: What is it and what can you do about it?</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[N. Hindle]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">This paper presents a summary of my experience with treatment of 41 patients with retinopathy of prematurity. From November, 1976, to June, 1988, 76 eyes with Stage 3b, 3c, and Stage 4 ROP had treatment to the ridge-EFP complex, the avascular retina, or both locations. Cryotherapy was used in all eyes, with two having Argon laser photocoagulation as well. These studies have shown that: 7.9% of all treated eyes had Grade III to V RLF; the optimal timing of intervention is recommended during progression of Stage 3b+ ROP; the optimal location of treatment appears to be the avascular retina with the ridge-EFP perhaps as effective but the treatment of both areas simultaneously is to be avoided due to an increased occurrence of grade II RLF and macular pigment epitheliopathy in those eyes so treated. A comparison of results of four major studies indicate that the U.S. Cryo-ROP Study has three times the rate of Grade III to V RLF, probably because of intervention after the accumulation of excessive quantities of Stage 3b and/or 3c ROP.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Kluwer Academic Publishers, 1990</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">retinopathy of prematurity</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">cryotherapy</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">photocoagulation</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">classification</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">complications</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">EFP : extraretinal fibrovascular proliferation</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">MPE : macular pigment epitheliopathy</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">RLF : cicatricial retinopathy of prematurity or retrolental fibroplasia</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">ROP : retinopathy of prematurity</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Documenta Ophthalmologica</subfield>
   <subfield code="d">Kluwer Academic Publishers</subfield>
   <subfield code="g">74/3(1990-03-01), 253-262</subfield>
   <subfield code="x">0012-4486</subfield>
   <subfield code="q">74:3&lt;253</subfield>
   <subfield code="1">1990</subfield>
   <subfield code="2">74</subfield>
   <subfield code="o">10633</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/BF02482616</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/BF02482616</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">100</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Hindle</subfield>
   <subfield code="D">N.</subfield>
   <subfield code="u">Alberta Children's Hospital &amp; Foothills Hospital, Calgary, Canada</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Documenta Ophthalmologica</subfield>
   <subfield code="d">Kluwer Academic Publishers</subfield>
   <subfield code="g">74/3(1990-03-01), 253-262</subfield>
   <subfield code="x">0012-4486</subfield>
   <subfield code="q">74:3&lt;253</subfield>
   <subfield code="1">1990</subfield>
   <subfield code="2">74</subfield>
   <subfield code="o">10633</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
